AKT1 and cervical carcinoma: To investigate the role of AKT phosphorylation in the cisplatin resistance in cervical cancer cells, we then measured the viability of cisplatin-treated Hela and Caski cells, in the presence of PI3K/Akt inhibitor, LY294002.